Skip to main content Accessibility help
×
Home

Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia

  • Guillaume Butler-Laporte (a1) (a2), Matthew P. Cheng (a1) (a2) (a3), Emily G. McDonald (a3) (a4) (a5) and Todd C. Lee (a1) (a3) (a4) (a5)

Abstract

Background and objective:

Enterococcus causes clinically significant bloodstream infections (BSIs). In centers with a higher prevalence of vancomycin resistant enterococcus (VRE) colonization, a common clinical question is whether empiric treatment directed against VRE should be initiated in the setting of a suspected enterococcal BSI. Unfortunately, VRE treatment options are limited, and relatively expensive, and subject patients to the risk of adverse reactions. We hypothesized that the results of VRE colonization screening could predict vancomycin resistance in enterococcal BSI.

Methods:

We reviewed 370 consecutive cases of enterococcal BSI over a 7-year period at 2 tertiary-care hospitals to determine whether vancomycin-resistant BSIs could be predicted based on known colonization status (ie, patients with swabs performed within 30 days, more remotely, or never tested). We calculated sensitivity and specificity, and we plotted negative predictives values (NPVs) and positive predictive values (PPVs) as a function of prevalence.

Results:

A negative screening swab within 30 days of infection yielded NPVs of 90% and 95% in settings where <27.0% and 15.0% of enterococcal BSI are resistant to vancomycin, respectively. In patients with known VRE colonization, the PPV for VRE in enterococcal BSI was >50% at any prevalence exceeding 25%.

Conclusions:

The results of a negative VRE screening test result performed within 30 days can help eliminate unnecessary empiric therapy in patients with suspected enterococcal BSI. Conversely, patients with positive VRE screening swabs require careful consideration of empiric VRE-directed therapy when enterococcal BSI appears likely.

Copyright

Corresponding author

Author for correspondence: Guillaume Butler-Laporte, E-mail: guillaume.butler-laporte@mail.mcgill.ca

References

Hide All
1.Ramsey, AM, Zilberberg, MD.Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000–2006. Infect Control Hosp Epidemiol 2009;30:184186.
2.Fridkin, SK, Edwards, JR, Courval, JM, et al.The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001;135:175183.
3.Suppola, JP, Volin, L, Valtonen, VV, Vaara, M.Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 1996;23:694697.
4.Mikulska, M, Del Bono, V, Raiola, AM, et al.Bloodstream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009;15:4753.
5.Bedini, A, Codeluppi, M, Cocchi, S, et al.Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc 2007;39:19471949.
6.French, G.Safety and tolerability of linezolid. J Antimicrob Chemother 2003;51 suppl 2:ii45ii53.
7.Foolad, F, Taylor, BD, Shelburne, SA, Arias, CA, Aitken, SL.Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review. J Antimicrob Chemother 2018;73:22772283.
8.Chuang, Y-C, Lin, H-Y, Chen, P-Y, et al.Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia. Clin Infect Dis 2017;64:10261034.
9.Bagga, B, Buckingham, S, Arnold, S, Nesbitt, A, Guimera, D, Lee, K.Increasing linezolid-resistant Enterococcus in a children’s hospital. Pediatr Infect Dis J 2018;37:242244.
10.Ye, J Jr, Shie, S-S, Cheng, C-W, et al.Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia. J Microbiol Immunol Infect 2018;51:705716.
11.Butler-Laporte, G, Cheng, MP, Cheng, AP, McDonald, EG, Lee, TC.Using MRSA screening tests to predict methicillin resistance in Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2016;60:74447448.
12.Butler-Laporte, G, De L’Etoile-Morel, S, Cheng, MP, McDonald, EG, Lee, TC.MRSA colonization status as a predictor of clinical infection: a systematic review and meta-analysis. J Infect 2018;77:489495.
13.Brasg, I, Elligsen, M, MacFadden, D, Daneman, N.Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort study. CMAJ Open 2017;5(3):E632E637.
14.Webb, BJ, Healy, R, Majers, J, et al.Prediction of bloodstream infection due to vancomycin-resistant Enterococcus in patients undergoing leukemia induction or hematopoietic stem-cell transplantation. Clin Infect Dis 2017;64:17531759.
15.Clinical and Laboratory Standards Institute. CLSI Document M100. Performance Standards for Antimicrobial Susceptibility Testing, 29th edition. Wayne, PA: CLSI; 2019.
16.McCracken, M, Wong, A, Mitchell, R, et al.Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999–2009. J Antimicrob Chemother 2013;68:15051509.
17.McDonald, EG, Dendukuri, N, Frenette, C, Lee, TC.Time-series analysis of health care-associated infections in a new hospital with all private rooms. JAMA Intern Med 2019;179:15011506.
18.Efron, B, Tibshirani, RJ.An Introduction to the Bootstrap, vol. 57, 1st ed. New York: Chapman and Hall; 1993.
19.Butler-Laporte, G, Cheng, MP, McDonald, EG, Lee, TC.Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia. BMC Infect Dis 2018;18:270.
20.Rubinstein, M, Hirsch, R, Bandyopadhyay, K, et al.Effectiveness of practices to support appropriate laboratory test utilization: a laboratory medicine best practices systematic review and meta-analysis. Am J Clin Pathol 2018;149:197221.
21.Bossaer, JB, Hall, PD, Garrett-Mayer, E.Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2011;19:231237.
22.Ford, CD, Lopansri, BK, Haydoura, S, et al.Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infection Control Hosp Epidemiol 2015;36:4753.
23.MacFadden, DR, Coburn, B, Shah, N, et al.Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to gram-negative pathogens: a multicentre observational cohort study. Clin Microbiol Infect 2018;24:493499.
Type Description Title
WORD
Supplementary materials

Butler-Laporte et al. supplementary material
Butler-Laporte et al. supplementary material

 Word (262 KB)
262 KB

Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia

  • Guillaume Butler-Laporte (a1) (a2), Matthew P. Cheng (a1) (a2) (a3), Emily G. McDonald (a3) (a4) (a5) and Todd C. Lee (a1) (a3) (a4) (a5)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed